The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALPINE IMMUNE SCIENCES INC COM 02083G100   72,693,429 3,813,926 SH   OTR 1 0 3,813,926 0
AUTOLUS THERAPEUTICS PLC SPON ADS 05280R100   11,968,154 1,858,409 SH   OTR 1 0 1,858,409 0
BIONOMICS LIMITED ADS 09063M205   1,219,971 824,305 SH   OTR 1 0 824,305 0
C4 THERAPEUTICS INC COM STK 12529R107   17,709,337 3,134,396 SH   OTR 1 0 3,134,396 0
CABALETTA BIO INC COM 12674W109   47,906,103 2,110,401 SH   OTR 1 0 2,110,401 0
GH RESEARCH PLC ORDINARY SHARES G3855L106   10,663,979 1,838,617 SH   OTR 1 0 1,838,617 0
KINNATE BIOPHARMA INC COM 49705R105   4,732,904 1,997,006 SH   OTR 1 0 1,997,006 0
MERUS N V COM N5749R100   31,218,688 1,135,225 SH   OTR 1 0 1,135,225 0
NEKTAR THERAPEUTICS COM 640268108   1,089,997 1,929,198 SH   OTR 1 0 1,929,198 0
PASSAGE BIO INC COM 702712100   382,951 379,159 SH   OTR 1 0 379,159 0
PIERIS PHARMACEUTICALS INC COM 720795103   1,779,205 9,775,849 SH   OTR 1 0 9,775,849 0
SILENCE THERAPEUTICS PLC ADS 82686Q101   4,095,620 235,787 SH   OTR 1 0 235,787 0
STOKE THERAPEUTICS INC COM 86150R107   15,553,389 2,956,918 SH   OTR 1 0 2,956,918 0
THESEUS PHARMACEUTICALS INC COM 88369M101   2,844,781 702,415 SH   OTR 1 0 702,415 0
TSCAN THERAPEUTICS INC COM 89854M101   30,459,418 5,224,600 SH   OTR 1 0 5,224,600 0